CIK 0001339970 · Non-accelerated filer<br>Smaller reporting company
aTYR PHARMA INC
Sign in to watch- Ticker
- ATYR
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 203435077
- Phone
- 8587318389
- Business address
- 10240 SORRENTO VALLEY ROAD, SUITE 300, SAN DIEGO, CA, 92121
- 4 Derivatives Options or other derivatives
- 8-K Event Material agreement · New debt or obligation · Unregistered share sale
- 4 Open-market buy 10% owner bought 29,607 shares at an average $4.84 ($143,333)
- 8-K Event Executive or director change
- 10-Q Report Quarterly Report
- 8-K Event Results of operations
- 4 Derivatives Options or other derivatives
- 8-K Event Executive or director change · Regulation FD disclosure
- 8-K Event Other events
- EFFECT Other Notice of Effectiveness
- CORRESP Other Correspondence Between Filers and SEC Staff
- CT ORDER Other Confidential Order
- D Other Notice of Sales of Unregistered Securities
- S-3 Offering Registration Statement
- SC 13G Stake Amended Statement of Ownership
- 3 Insider Initial Statement of Ownership
- SC 13G/A Stake Amended Statement of Ownership
- 4 Open-market buy Director bought 94,336 shares at $2.65 ($249,990)
- 4 Open-market buy CEO and Director bought 37,736 shares at $2.65 ($100,000)
- 8-K Event Bylaws or fiscal year change
Page 25 of 38 · 755 filings